Black Rock Inc. Pliant Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLRX
# of Institutions
165Shares Held
63.1MCall Options Held
275KPut Options Held
159K-
Deep Track Capital, LP Greenwich, CT5.97MShares$76.7 Million2.47% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.83MShares$62.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$45.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.2MShares$41.1 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.1MShares$39.9 Million1.25% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $626M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...